What Now For Aerpio harmaceuticals (NASDAQ:ARPO)?

ARPO is trading up on news pre market.

Market Action

As of 7:36 almost 1 million shares have traded with the last price at 1.25 up 7%

ARPO Issues News

Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive Merger Agreement

  • Transaction to create Nasdaq-listed company focused on advancing Aadi Bioscience’s late-stage pipeline for genetically-defined cancers with alterations in mTOR pathway genes
  • Concurrent $155 million PIPE financing is backed by leading life science investors led by Acuta Capital Partners and KVP Capital and including Avoro Capital Advisors; Avoro Ventures; Venrock Healthcare Capital Partners; BVF Partners, L.P.; Vivo Capital; Alta Bioequities, L.P.; Rock Springs Capital; RTW Investments, LP; Acorn Bioventures; and Serrado Capital LLC
  • Combined company cash at closing will fund operations into 2024
  • Rolling NDA submission to the FDA for FYARRO TM in advanced malignant perivascular epithelioid sarcoma (PEComa) expected to be completed in mid-2021
  • FYARRO TM preliminary data in patients with solid tumors harboring inactivating alterations in the mTOR pathway genes TSC1 and TSC2 to be presented at ASCO 2021 1
  • FYARRO TM tumor-agnostic registrational trial in solid tumors harboring inactivating alterations in the mTOR pathway genes TSC1 and TSC2 expected to be initiated by the end of 2021

Trader Notes

Recent Stock Performance

5-DAY PERF.+10.48%
1-MONTH PERF.-7.20%
3-MONTH PERF.-42.86%
6-MONTH PERF.-30.95%
YTD PERF.+18.37%
1-YEAR PERF.+59.45%

Moving Averages

+/- EMA(20)1.14 (+1.75%)
+/- SMA(50)1.32 (-12.12%)
+/- SMA(200)1.42 (-18.31%)

Pivot Points

NameS3S2S1Pivot PointsR1R2R3

Technical Indicators

CCI2030.5953NeutralChaikin Money Flow-0.0498Neutral
MACD-0.0836SellMoney Flow Index43.1310Sell
STOCH (14,3)80.4611OverBoughtSTOCH RSI1.0000OverBought
UO52.1588BuyWilliams %R-19.5389OverBought

Related Posts

About The Author